Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice

Neuropharmacology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles